Discovery of potent and specific fructose-1,6-bisphosphatase inhibitors and a series of orally-bioavailable phosphoramidase-sensitive prodrugs for the treatment of type 2 diabetes.
J Am Chem Soc
; 129(50): 15491-502, 2007 Dec 19.
Article
in En
| MEDLINE
| ID: mdl-18041834
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prodrugs
/
Fructose-Bisphosphatase
/
Diabetes Mellitus, Type 2
/
Enzyme Inhibitors
/
Hydrolases
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
J Am Chem Soc
Year:
2007
Document type:
Article
Affiliation country:
United States
Country of publication:
United States